Junevity, a pioneering biotechnology company with the ambitious mission of extending human healthspan through advanced cell reprogramming, today announced it has successfully expanded its Seed financing to a total of $20 million with an additional $10 million investment. The new capital was jointly led by Goldcrest Capital and Godfrey Capital, providing the runway necessary to…
Aether Biomachines, an American artificial intelligence company focused on delivering real-world industrial solutions using AI-designed proteins, today announced it has raised an additional $15 million in funding. The round was led by Tribe Capital, with significant participation from both new and existing investors, including Natural Capital, Henkel Corporation, Resilience Reserve, Shrug Capital, 4DX Ventures, Unless…
In an industry where clinical timelines stretch a decade and financing cycles can make or break scientific ambition, Morphocell Technologies has pulled off a milestone that places it among Canada’s most serious regenerative-medicine contenders. The Montreal-based biotechnology company has completed its full US$50 million Series A raise, adding a fresh US$10 million extension round led…
